Mati Therapeutics, Inc. v. Ocular Therapeutix, Inc.

Full title: MATI THERAPEUTICS, INC., Appellant v. OCULAR THERAPEUTIX, INC., Appellee

Court: United States Court of Appeals, Federal Circuit

Date published: Nov 8, 2021

No. 2020-2176 (Fed. Cir. Nov. 8, 2021)

Opinion

2020-2176

11-08-2021

MATI THERAPEUTICS, INC., Appellant v. OCULAR THERAPEUTIX, INC., Appellee

Henry Huang, White & Case LLP, Palo Alto, CA, argued for appellant. Also represented by Hallie Elizabeth Kiernan, Yang Xu; David Tennant, Washington, DC; Anita Varma, Boston, MA. Jennifer L. Swize, Jones Day, Washington, DC, argued for appellee. Also represented by Gregory A. Castanias, Amelia A. DeGory; John Joseph Normile, Jr., New York, NY.

PER CURIAM

This disposition is nonprecedential.

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2019-00448.

Henry Huang, White & Case LLP, Palo Alto, CA, argued for appellant. Also represented by Hallie Elizabeth Kiernan, Yang Xu; David Tennant, Washington, DC; Anita Varma, Boston, MA.

Jennifer L. Swize, Jones Day, Washington, DC, argued for appellee. Also represented by Gregory A. Castanias, Amelia A. DeGory; John Joseph Normile, Jr., New York, NY.

JUDGMENT

THIS CAUSE having been heard and considered, it is

ORDERED AND ADJUDGED:

PER CURIAM

Lourie, O'Malley, and Stoll, Circuit Judges.

AFFIRMED. See Fed. Cir. R. 36.